This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.
Federal Disaster Resources
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Texas for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Texas’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the Territory of the United States Virgin Islands for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on January 13, 2021 indicated the United State Virgin Islands’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Washington for multiple section 1135 flexibilities on March 19, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Washington’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Virginia for multiple section 1135 flexibilities on May 19, 2020. Your follow-up communication to CMS on December 31, 2020 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Virginia and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Utah for multiple section 1135 flexibilities on April 10, 2020. Your follow-up communication to CMS on January 15, 2021, indicated Utah’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Jersey for multiple section 1135 flexibilities on March 23, 2020 Your follow-up communication to CMS on January 14, 2021 indicated New Jersey’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Michigan for multiple section 1135 flexibilities on April 6, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Michigan’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Virginia for multiple section 1135 flexibilities on May 19, 2020. Your follow-up communication to CMS on January 22, 2021 indicated Virginia's response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the Commonwealth of Kentucky for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Kentucky’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the District of Columbia (DC) for multiple section 1135 flexibilities on April 3, 2020. Your follow-up communication to CMS on January 13, 2021 indicated DC’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show
entries